Early protocol biopsies in pediatric renal transplantation: Interest for the adaptation of immunosuppression
Alexandra Bruel
Department of Pediatrics, Nantes University Hospital, Nantes, France
Search for more papers by this authorEmma Allain-Launay
Department of Pediatrics, Nantes University Hospital, Nantes, France
Search for more papers by this authorJulie Humbert
Department of Pediatrics, Nantes University Hospital, Nantes, France
Search for more papers by this authorAmélie Ryckewaert
Department of Pediatrics, Rennes University Hospital, Rennes, France
Search for more papers by this authorGérard Champion
Department of Pediatrics, Angers University Hospital, Angers, France
Search for more papers by this authorAnne Moreau
Department of Anatomopathology, Nantes University Hospital, Nantes, France
Search for more papers by this authorKarine Renaudin
Department of Anatomopathology, Nantes University Hospital, Nantes, France
Search for more papers by this authorGeorges Karam
Department of Urology and Renal Transplantation, Nantes University Hospital, Nantes, France
Search for more papers by this authorCorresponding Author
Gwenaelle Roussey-Kesler
Department of Pediatrics, Nantes University Hospital, Nantes, France
Gwenaelle Roussey-Kesler, Clinique Medicale Pediatrique, Hopital Mère enfants, Centre Hospitalier Universitaire, Quai Moncousu, 44093 Nantes, France
Tel.: +33 2 40 08 36 60
Fax: +33 2 40 08 36 65
E-mail: [email protected]
Search for more papers by this authorAlexandra Bruel
Department of Pediatrics, Nantes University Hospital, Nantes, France
Search for more papers by this authorEmma Allain-Launay
Department of Pediatrics, Nantes University Hospital, Nantes, France
Search for more papers by this authorJulie Humbert
Department of Pediatrics, Nantes University Hospital, Nantes, France
Search for more papers by this authorAmélie Ryckewaert
Department of Pediatrics, Rennes University Hospital, Rennes, France
Search for more papers by this authorGérard Champion
Department of Pediatrics, Angers University Hospital, Angers, France
Search for more papers by this authorAnne Moreau
Department of Anatomopathology, Nantes University Hospital, Nantes, France
Search for more papers by this authorKarine Renaudin
Department of Anatomopathology, Nantes University Hospital, Nantes, France
Search for more papers by this authorGeorges Karam
Department of Urology and Renal Transplantation, Nantes University Hospital, Nantes, France
Search for more papers by this authorCorresponding Author
Gwenaelle Roussey-Kesler
Department of Pediatrics, Nantes University Hospital, Nantes, France
Gwenaelle Roussey-Kesler, Clinique Medicale Pediatrique, Hopital Mère enfants, Centre Hospitalier Universitaire, Quai Moncousu, 44093 Nantes, France
Tel.: +33 2 40 08 36 60
Fax: +33 2 40 08 36 65
E-mail: [email protected]
Search for more papers by this authorAbstract
GPB are often performed in PRT to detect subclinical acute rejection or IF/TA. Reducing immunosuppression side effects without increasing rejection is a major concern in PRT. We report the results of GPB in children transplanted with a steroid-sparing protocol adapted to immunological risk. Children under 18 yr who received a renal transplantation between April 1, 2009 and May 31, 2012 were included. Immunosuppression consisted of an antibody induction therapy, tacrolimus, and MMF for all recipients. CSs were administered to children under five yr old, or receiving a second allograft. Twenty-eight children were included, 50% were CSs free. GPB were performed between three and six months. IF/TA was documented in seven biopsies; four of these seven children were CS free. One child, with CSs, presented a borderline rejection, and another child, steroid free, with significant inflammatory interstitial infiltrate, considered as a subclinical rejection, was treated with CSs pulses. The median eGFR was stable (74, 67.5, and 82 mL/min/1.73 m² at, respectively, seven days, three months, and one yr). Patient and graft survival were 100%. These results have to be confirmed in a larger cohort, with long-term follow-up.
References
- 1Roussey-Kesler G, Decramer S. Outcomes of pediatric renal transplantation in France. Nephrol Ther 2011: 7: 611–617.
- 2El-Zoghby ZM, Stegall MD, Lager DJ, et al. Identifying specific causes of kidney allograft loss. Am J Transplant 2009: 9: 527–535.
- 3Dart AB, Schall A, Gibson IW, Blydt-Hansen TD, Birk PE. Patterns of chronic injury in pediatric renal allografts. Transplantation 2010: 89: 334–340.
- 4Nankivell BJ, Borrows RJ, Fung CL-S, O'Connell PJ, Allen RDM, Chapman JR. The natural history of chronic allograft nephropathy. N Engl J Med 2003: 349: 2326–2333.
- 5Nankivell BJ, Kuypers DRJ. Diagnosis and prevention of chronic kidney allograft loss. Lancet 2011: 378: 1428–1437.
- 6Naesens M, Kuypers DRJ, Sarwal M. Calcineurin inhibitor nephrotoxicity. Clin J Am Soc Nephrol 2009: 4: 481–508.
- 7Flechner SM, Kobashigawa J, Klintmalm G. Calcineurin inhibitor-sparing regimens in solid organ transplantation: Focus on improving renal function and nephrotoxicity. Clin Transplant 2008: 22: 1–15.
- 8Einecke G, Sis B, Reeve J, et al. Antibody-mediated microcirculation injury is the major cause of late kidney transplant failure. Am J Transplant 2009: 9: 2520–2531.
- 9Birk PE. Surveillance biopsies in children post-kidney transplant. Pediatr Nephrol 2012: 27: 753–760.
- 10Choi BS, Shin MJ, Shin SJ, et al. Clinical significance of an early protocol biopsy in living-donor renal transplantation: Ten-year experience at a single center. Am J Transplant 2005: 5: 1354–1360.
- 11Nankivell BJ, Borrows RJ, Fung CL-S, O'Connell PJ, Allen RDM, Chapman JR. Natural history, risk factors, and impact of subclinical rejection in kidney transplantation. Transplantation 2004: 78: 242–249.
- 12Schwarz A, Mengel M, Gwinner W, et al. Risk factors for chronic allograft nephropathy after renal transplantation: A protocol biopsy study. Kidney Int 2005: 67: 341–348.
- 13Moreso F, Ibernon M, Gomà M, et al. Subclinical rejection associated with chronic allograft nephropathy in protocol biopsies as a risk factor for late graft loss. Am J Transplant 2006: 6: 747–752.
- 14Ettenger RB. Age and the immune response in pediatric renal transplantation. Eur J Pediatr 1992: 151(Suppl 1): S7–S8.
- 15Scornik JC, Pfaff WW, Howard RJ, et al. Increased antibody responsiveness to blood transfusions in pediatric patients. Transplantation 1994: 58: 1361–1365.
- 16Birk PE, Stannard KM, Konrad HB, et al. Surveillance biopsies are superior to functional studies for the diagnosis of acute and chronic renal allograft pathology in children. Pediatr Transplant 2004: 8: 29–38.
- 17Bunchman TE, Fryd DS, Sibley RK, Mauer SM. Manifestations of renal allograft rejection in small children receiving adult kidneys. Pediatr Nephrol 1990: 4: 255–258.
- 18Kanzelmeyer NK, Ahlenstiel T, Drube J, et al. Protocol biopsy-driven interventions after pediatric renal transplantation. Pediatr Transplant 2010: 14: 1012–1018.
- 19Vaudry W, Ettenger R, Jara P, et al. Valganciclovir dosing according to body surface area and renal function in pediatric solid organ transplant recipients. Am J Transplant 2009: 9: 636–643.
- 20Schwartz GJ, Muñoz A, Schneider MF, et al. New equations to estimate GFR in children with CKD. J Am Soc Nephrol 2009: 20: 629–637.
- 21Froissart M, Rossert J, Jacquot C, Paillard M, Houillier P. Predictive performance of the modification of diet in renal disease and Cockcroft-Gault equations for estimating renal function. J Am Soc Nephrol 2005: 16: 763–773.
- 22Solez K, Colvin RB, Racusen LC, et al. Banff “05 Meeting Report: Differential diagnosis of chronic allograft injury and elimination of chronic allograft nephropathy (“CAN”). Am J Transplant 2007: 7: 518–526.
- 23Piovesan AC, Lucon AM, David DSR, Nahas WC, Antonopoulos IM, Srougi M. Multifocal renal allograft biopsy: Impact on therapeutic decisions. Transplant Proc 2008: 40: 3397–3400.
- 24Heilman RL, Devarapalli Y, Chakkera HA, et al. Impact of subclinical inflammation on the development of interstitial fibrosis and tubular atrophy in kidney transplant recipients. Am J Transplant 2010: 10: 563–570.
- 25Shishido S, Asanuma H, Nakai H, et al. The impact of repeated subclinical acute rejection on the progression of chronic allograft nephropathy. J Am Soc Nephrol 2003: 14: 1046–1052.
- 26Thierry A, Thervet E, Vuiblet V, et al. Long-term impact of subclinical inflammation diagnosed by protocol biopsy one year after renal transplantation. Am J Transplant 2011: 11: 2153–2161.
- 27Moreso F, Carrera M, Goma M, et al. Early subclinical rejection as a risk factor for late chronic humoral rejection. Transplantation 2012: 93: 41–46.
- 28Naesens M, Kambham N, Concepcion W, Salvatierra O Jr, Sarwal M. The evolution of nonimmune histological injury and its clinical relevance in adult-sized kidney grafts in pediatric recipients. Am J Transplant 2007: 7: 2504–2514.
- 29Giuliani S, Gamba PG, Chokshi NK, Gasparella P, Murer L, Zanon GF. The effect of donor/recipient body surface area ratio on outcomes in pediatric kidney transplantation. Pediatr Transplant 2009: 13: 290–299.
- 30Veenstra DL, Best JH, Hornberger J, Sullivan SD, Hricik DE. Incidence and long-term cost of steroid-related side effects after renal transplantation. Am J Kidney Dis 1999: 33: 829–839.
- 31Hricik DE, O'Toole MA, Schulak JA, Herson J. Steroid-free immunosuppression in cyclosporine-treated renal transplant recipients: A meta-analysis. J Am Soc Nephrol 1993: 4: 1300–1305.
- 32Delucchi A, Valenzuela M, Lillo AM, et al. Early steroid withdrawal in pediatric renal transplant: Five years of follow-up. Pediatr Nephrol 2011: 26: 2235–2244.
- 33Sarwal MM, Vidhun JR, Alexander SR, Satterwhite T, Millan M, Salvatierra O Jr. Continued superior outcomes with modification and lengthened follow-up of a steroid-avoidance pilot with extended daclizumab induction in pediatric renal transplantation. Transplantation 2003: 76: 1331–1339.
- 34Höcker B, Weber LT, Feneberg R, et al. Improved growth and cardiovascular risk after late steroid withdrawal: 2-year results of a prospective, randomised trial in paediatric renal transplantation. Nephrol Dial Transplant 2010: 25: 617–624.
- 35Grenda R. Steroid withdrawal in renal transplantation. Pediatr Nephrol 2013: 28: 2107–2112.
- 36Sarwal MM, Yorgin PD, Alexander S, et al. Promising early outcomes with a novel, complete steroid avoidance immunosuppression protocol in pediatric renal transplantation. Transplantation 2001: 72: 13–21.
- 37Sarwal MM, Ettenger RB, Dharnidharka V, et al. Complete steroid avoidance is effective and safe in children with renal transplants: A multicenter randomized trial with three-year follow-up. Am J Transplant 2012: 12: 2719–2729.
- 38Grenda R, Watson A, Trompeter R, et al. A randomized trial to assess the impact of early steroid withdrawal on growth in pediatric renal transplantation: The TWIST study. Am J Transplant 2010: 10: 828–836.
- 39Al-Sinani S, Dhawan A. Corticosteroids usage in pediatric liver transplantation: To be or not to be! Pediatr Transplant 2009: 13: 160–170.
- 40Iorember FM, Patel HP, Ohana A, et al. Steroid avoidance using sirolimus and cyclosporine in pediatric renal transplantation: One year analysis. Pediatr Transplant 2010: 14: 93–99.
- 41Gupta P, Hart J, Millis JM, Cronin D, Brady L. De novo hepatitis with autoimmune antibodies and atypical histology: A rare cause of late graft dysfunction after pediatric liver transplantation. Transplantation 2001: 71: 664–668.
- 42Seikku P, Raivio T, Jänne OA, Neuvonen PJ, Holmberg C. Methylprednisolone exposure in pediatric renal transplant patients. Am J Transplant 2006: 6: 1451–1458.